![Jeenjoo Kang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeenjoo Kang
Fondateur chez
Appia Bio, Inc.
Profil
JeenJoo S Kang is the founder of Appia Bio, Inc. since 2020, holding the title of Chief Executive Officer & Director.
Dr. Kang is currently on the Board of Directors at Escient Pharmaceuticals, Inc. Former positions include Director at Exonics Therapeutics, Inc. from 2017 to 2020, Independent Director at Tenaya Therapeutics, Inc. from 2016 to 2021, and Venture Partner at The Column Group LLC from 2020 to 2022.
Education includes an undergraduate degree from Harvard University and a doctorate from California Institute of Technology, conferred in 2015.
Postes actifs de Jeenjoo Kang
| Sociétés | Poste | Début |
|---|---|---|
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Develops cell therapies | Fondateur | 01/01/2020 |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeenjoo Kang
| Sociétés | Poste | Fin |
|---|---|---|
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Analyste en capital-investissement | 01/01/2017 |
| TENAYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/11/2021 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Directeur/Membre du Conseil | 30/08/2020 |
Formation de Jeenjoo Kang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Appia Bio, Inc.
Appia Bio, Inc. BiotechnologyHealth Technology Develops cell therapies | Health Technology |
